Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

The commonest manifestations of cardiovascular disease, namely coronary heart disease (CHD) and stroke, represent the two most common causes of death in the world today. Furthermore, cardiovascular diseases have the highest healthcare utilisation costs in most countries. Both primary and secondary p...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteur:	Hobbs, F
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2003

Gelijkaardige items

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
door: article Editorial
Gepubliceerd in: (2020-09-01)

Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.
door: Hobbs, R, et al.
Gepubliceerd in: (2005)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
door: Alberto J Lorenzatti, et al.
Gepubliceerd in: (2020-02-01)

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
door: Mach, F, et al.
Gepubliceerd in: (2019)

Biochemical effects of statins on lipid parameters among newly diagnosed dyslipidaemia subjects in primary care
door: Meor Anuar Shuhaili, Meor Fairuz Rizal, et al.
Gepubliceerd in: (2018)

Seasonal variation lipid levels in the patients with dyslipidaemia
door: I V Radysh, et al.
Gepubliceerd in: (2009-12-01)

Cardiovascular risk management in primary care.
door: Hobbs, F
Gepubliceerd in: (2002)

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
door: Francois Mach, et al.
Gepubliceerd in: (2020-06-01)

Dyslipidaemia—Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease
door: Sung-Bum Lee, et al.
Gepubliceerd in: (2022-07-01)

Current insights on dyslipidaemia management for prevention of atherosclerotic cardiovascular disease: a malaysian perspective
door: Wan Ahmad, Wan Azman, et al.
Gepubliceerd in: (2023)

Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
door: M R Essop, et al.
Gepubliceerd in: (2023-11-01)

Managing dyslipidaemia in patients with chronic kidney disease
door: Ashwani Mehta
Gepubliceerd in: (2024-03-01)

Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
door: Alicja E. Grzegorzewska, et al.
Gepubliceerd in: (2021-03-01)

Serum zinc levels in diabetic patients with and without dyslipidaemia and cardiovascular diseases
door: Lakmal Jayaweera, et al.
Gepubliceerd in: (2020-08-01)

Role of dyslipidaemia and lipid peroxidation in pregnancy induced hypertension
door: Saxena S, et al.
Gepubliceerd in: (2015-07-01)

New concepts in the management of dyslipidaemia
door: Baris Gencer, et al.
Gepubliceerd in: (2016-11-01)

Managing dyslipidaemia in young adults
door: Jamshed J. Dalal, et al.
Gepubliceerd in: (2024-03-01)

Role of statins in the management of dyslipidaemia
door: Saumitra Ray
Gepubliceerd in: (2024-03-01)

The changing paradigm of dyslipidaemia management
door: Ruvan Ekanayaka
Gepubliceerd in: (2017-04-01)

Update on the Management of Diabetic Dyslipidaemia
door: Iciar Martín-Timón, et al.
Gepubliceerd in: (2018-11-01)

The scale of heart failure: diagnosis and management issues for primary care.
door: Hobbs, F
Gepubliceerd in: (1999)

Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia.
door: Hobbs, F
Gepubliceerd in: (2004)

Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
door: Maciej Banach, et al.
Gepubliceerd in: (2022-09-01)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
door: Alberto Zambon
Gepubliceerd in: (2020-04-01)

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia
door: Di Liu, et al.
Gepubliceerd in: (2018-08-01)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
door: Anandita Agarwala, et al.
Gepubliceerd in: (2020-02-01)

Established and Emerging Approaches for the Management of Dyslipidaemia
door: Giuseppe Danilo Norata
Gepubliceerd in: (2012-01-01)

Secondary dyslipidaemia
door: D.J. Blom
Gepubliceerd in: (2011-07-01)

Diabetic dyslipidaemia
door: Subashini C. Thambiah, et al.
Gepubliceerd in: (2021-08-01)

Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia
door: Martina Meszaros, et al.
Gepubliceerd in: (2022-10-01)

Lipid management in cardiovascular disease prevention guidelines: strategies and tactics for implementation.
door: Erhardt, L, et al.
Gepubliceerd in: (2008)

Effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau: a quality improvement study
door: In Wong, et al.
Gepubliceerd in: (2020-01-01)

Optimisation of lipids for prevention of cardiovascular disease in a primary care
door: Smita Bakhai, et al.
Gepubliceerd in: (2018-07-01)

Role of PCSK9 inhibitors in the management of dyslipidaemia
door: Tiny Nair
Gepubliceerd in: (2024-03-01)

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
door: Alberico L. Catapano, et al.
Gepubliceerd in: (2017-06-01)

Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45-64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors.
door: Dalia Luksiene, et al.
Gepubliceerd in: (2014-01-01)

Dyslipidaemia and inflammatory markers as the risk predictors for cardiovascular disease in newly diagnosed premenopausal hypothyroid women
door: Balamurugan Vaideki, et al.
Gepubliceerd in: (2023-01-01)

Dyslipidaemia in endocrine disorders
door: Kalyani Sridharan, et al.
Gepubliceerd in: (2024-03-01)

Treatment of Dyslipidaemia in Children
door: Riccardo Fiorentino, et al.
Gepubliceerd in: (2021-08-01)

Dyslipidaemia in Sri Lanka
door: Anne Thushara Matthias, et al.
Gepubliceerd in: (2022-01-01)